-
FDA Votes In Favor Of Removing Side-Effect Warning On Pfizer's Chantix
Thursday, September 15, 2016 - 8:57am | 444Pfizer Inc. (NYSE: PFE)'s Chantix is a prescription medication that helps adults 18 years and older quit smoking. The drug has been linked with reports of mental health problems, risk of suicide, depression and death in users, which prompted the U.S. Food and Drug Administration (FDA) to issue...
-
Eteplirsen Not Effective: Sarepta Therapeutics Plunges 50%
Tuesday, April 26, 2016 - 7:39am | 265Shares of Sarepta Therapeutics Inc (NASDAQ: SRPT) plunged 50 percent early Tuesday morning after a federal advisory panel voted that eteplirsen, its drug for the treatment of Duchenne muscular dystrophy (DMD), was not effective. The U.S. Food and Drug Administration voted 6-7 against the...